Kristy Coleman

Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial

Carolina R. A. Silveira, Julia MacKinley, Kristy Coleman et al. · BMC Neurology · 2019 · 131 citations · Full text

Medicine, Neurology, Pharmacology +17

Parsing cognitive and emotional empathy deficits for negative and positive stimuli in frontotemporal dementia

Lindsay D. Oliver, Derek Mitchell, Isabel Dziobek et al. · Neuropsychologia · 2014 · 65 citations

Medicine, Neurology, Neuroscience +15

Depressive Symptoms Negatively Impact Montreal Cognitive Assessment Performance: A Memory Clinic Experience

Mervin Blair, Kristy Coleman, Sarah Jesso et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2016 · 52 citations · Full text

Medicine, Psychiatry, Psychology +17

Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration

Tamara P. Tavares, Derek Mitchell, Kristy Coleman et al. · Journal of Neurology Neurosurgery & Psychiatry · 2020 · 42 citations · Full text

Medicine, Genetics, Neurology +17

Adaptive crossover designs for assessment of symptomatic treatments targeting behaviour in neurodegenerative disease: a phase 2 clinical trial of intranasal oxytocin for frontotemporal dementia (FOXY)

Elizabeth Finger, Scott Berry, Jeffrey Cummings et al. · Alzheimer s Research & Therapy · 2018 · 35 citations · Full text

Medicine, Pharmacology, Psychiatry +17